Clinical Trials
3 trialsNCT04868045 2023-02-21
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Withdrawn
NCT00054756 2018-08-08
Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00790296 2017-12-28
Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue
UConn Health
Phase 2 Terminated